Repligen Corporation manufactures bioprocessing equipment and consumables used in the production and testing of biopharmaceutical products. The company's portfolio spans filtration systems, chromatography columns and resins, process monitoring devices, and analytical tools for cell culture and drug purification, sold under multiple brand names to pharmaceutical manufacturers, contract manufacturers, and research organizations globally. Founded in 1981 and based in Massachusetts, Repligen serves the life sciences industry across North America, Europe, and Asia Pacific.

entry readiness 10 · NOT READY · exit proximity 0

Value area 136.23–196.91 · 25% of 120d volume overhead · moderate overhead